{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:21:38Z","timestamp":1791310898122,"version":"4.3.1"},"reference-count":16,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T00:00:00Z","timestamp":1232323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The sap of the plant <jats:italic>Euphorbia peplus<\/jats:italic> is a traditional remedy for skin conditions, including actinic keratosis. The active constituent of the sap is ingenol mebutate (ingenol\u20103\u2010angelate), formerly known as PEP005. This randomized, double\u2010blind, vehicle\u2010controlled, phase IIa study investigated the safety (and secondarily the efficacy) of two applications of ingenol mebutate gel in 58 patients with biopsy\u2010confirmed actinic keratosis. Five preselected lesions were treated with ingenol mebutate gel, 0.0025%, 0.01% or 0.05%, or vehicle gel, on days 1 and 2 (Arm A) or days 1 and 8 (Arm B). There were no significant differences in tolerability or efficacy between Arms A and B. Treatment was well tolerated. The most common local skin responses were dose\u2010related erythema, flaking\/scaling\/dryness and scabbing\/crusting. Efficacy was greatest with ingenol mebutate gel, 0.05%, which resulted in complete clinical clearance of 71% of treated lesions (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001 <jats:italic>vs<\/jats:italic> vehicle gel). In addition, 67% of patients treated with ingenol mebutate gel, 0.05% had clinical clearance of at least four of five treated lesions (<jats:italic>P<\/jats:italic>\u2003=\u20030.0185 <jats:italic>vs<\/jats:italic> vehicle gel). Ingenol mebutate gel is being developed as a short\u2010course topical therapy for actinic keratosis and non\u2010melanoma skin cancer.<\/jats:p>","DOI":"10.1111\/j.1440-0960.2008.00497.x","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:46:16Z","timestamp":1232412376000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: Results of a randomized, double\u2010blind, vehicle\u2010controlled, multicentre, phase IIa study"],"prefix":"10.1111","volume":"50","author":[{"given":"Greg","family":"Siller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Gebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Welburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Katsamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Ogbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00048.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2007.33224.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91658-3"},{"key":"e_1_2_7_5_2","first-page":"131","article-title":"Weeds of New South Wales","volume":"28","author":"Maiden JH","year":"1917","journal-title":"Ag. Gazette NSW"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1988.tb00383.x"},{"key":"e_1_2_7_7_2","unstructured":"AylwardJH inventor;Peplin Research Pty. Ltd assignee.Anti\u2010cancer compounds. US patent 6 787 161. 2004; 7 September."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2837"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.11.8123"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0458-9"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07121.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103344"},{"key":"e_1_2_7_13_2","first-page":"599","article-title":"Guideline Subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratoses","volume":"16","author":"Stockfleth E","year":"2006","journal-title":"Eur. J. Dermatol"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08267.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200001030-00004"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08268.x"},{"key":"e_1_2_7_17_2","first-page":"539","article-title":"Actinic keratoses","volume":"36","author":"Chia A","year":"2007","journal-title":"Aust. Fam. Physician"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2008.00497.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-0960.2008.00497.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:20:41Z","timestamp":1696875641000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2008.00497.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,19]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1440-0960.2008.00497.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2008.00497.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,19]]},"assertion":[{"value":"2009-01-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}